The Food and Drug Administration on Monday approved a drug for a wide range of cancers based on a shared mutation, rather than the tumors' locations — an advance for the sometimes controversial field of “precision medicine.”
FDA Approves 'Precision Medicine' for Cancers
Comment
Show comments
Hide Comments
